← Leaderboards
Douglas Alan Mitchell
University Of Illinois At Urbana-Champaign
$12,458,055
Attributed
$17,005,023
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2011–25$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,005,023 · 7
By mechanism
R01$12,002,547 · 3
DP2$2,377,500 · 1
R24$1,841,325 · 1
R35$558,651 · 1
R41$225,000 · 1
Top collaborators
- Willem A Van Der Donk7 shared
- Huimin Zhao7 shared
- John A Gerlt3 shared
- Mark J Burk1 shared
Most similar at University Of Illinois At Urbana-Champaign
Same institution · by research overlap
- John A Gerlt$49,592,476
- Sarah Louise Perry$1,245,163
- Paul R Selvin$15,958,940
- Nicole R Buan$970,855
- Kou-San Ju$1,728,438
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsNatural ProductsPeptidesGenomicsInterestSourceBioinformaticsStructureFamilyAnabolismGenomeEnzymesGenesGene ClusterPharmaceutical PreparationsRibosomesAntibioticsMiningSuccessBacteriaBaseChemistryMedicineNovel Therapeutics
Grant awards (42)
A Next-Generation Scalable Platform to Discover Antimicrobials of Ribosomal Origin$743,463
R01 · FY2025 · AI
Discovery and Engineering of RiPP Natural Products$558,651
R35 · FY2025 · GM · contact PI
A Next-Generation Scalable Platform to Discover Antimicrobials of Ribosomal Origin$743,463
R01 · FY2024 · AI
Web-Based Resource for Genomic Enzymology Tools$561,185
R24 · FY2024 · GM
Enzyme Chemistry and Biological Function of RiPP-like Modifications.$405,124
R01 · FY2024 · GM · contact PI
Genomics Accelerated Natural Product Discovery$190,586
R01 · FY2024 · GM · contact PI
Genomics Accelerated Natural Product Discovery$151,163
R01 · FY2024 · GM · contact PI
Genomics Accelerated Natural Product Discovery$23,026
R01 · FY2024 · GM · contact PI
Enzyme Chemistry and Biological Function of RiPP-like Modifications$1
R01 · FY2024 · GM · contact PI
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin$770,174
R01 · FY2023 · AI
Web-Based Resource for Genomic Enzymology Tools$561,185
R24 · FY2023 · GM
Characterization of YcaO-Dependent Natural Product Biosynthetic Pathways$326,169
R01 · FY2023 · GM · contact PI
Genomics Accelerated Natural Product Discovery$316,033
R01 · FY2023 · GM · contact PI
Genomics Accelerated Natural Product Discovery$120,896
R01 · FY2023 · GM · contact PI
Characterization of YcaO-Dependent Natural Product Biosynthetic Pathways$11,721
R01 · FY2023 · GM · contact PI
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin$770,174
R01 · FY2022 · AI
Web-Based Resource for Genomic Enzymology Tools$718,955
R24 · FY2022 · GM
Characterization of YcaO-Dependent Natural Product Biosynthetic Pathways$326,169
R01 · FY2022 · GM · contact PI
Genomics Accelerated Natural Product Discovery$316,033
R01 · FY2022 · GM · contact PI
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin$748,142
R01 · FY2021 · AI
Characterization of YcaO-Dependent Natural Product Biosynthetic Pathways$341,493
R01 · FY2021 · GM · contact PI
Genomics Accelerated Natural Product Discovery$282,087
R01 · FY2021 · GM · contact PI
Characterization of YcaO-Dependent Natural Product Biosynthetic Pathways$70,862
R01 · FY2021 · GM · contact PI
Genomics-Accelerated Natural Product Discovery$11,039
R01 · FY2021 · GM · contact PI
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin$749,232
R01 · FY2020 · AI
Characterization of YcaO-Dependent Natural Product Biosynthetic Pathways$337,662
R01 · FY2020 · GM · contact PI
Genomics-Accelerated Natural Product Discovery$281,723
R01 · FY2020 · GM · contact PI
A Genes-to-Molecules Platform for Expanding Natural Product Diversity$225,000
R41 · FY2020 · AT
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin$746,060
R01 · FY2019 · AI
Characterization of YcaO-Dependent Natural Product Biosynthetic Pathways$302,746
R01 · FY2019 · GM · contact PI
Genomics-Accelerated Natural Product Discovery$282,178
R01 · FY2019 · GM · contact PI
Characterization of YcaO-Dependent Natural Product Biosynthetic Pathways$303,297
R01 · FY2018 · GM · contact PI
Genomics-Accelerated Natural Product Discovery$282,621
R01 · FY2018 · GM · contact PI
Genomics Accelerated Natural Product Discovery$125,000
R01 · FY2018 · GM · contact PI
Characterization of YcaO-Dependent Natural Product Biosynthetic Pathways$303,831
R01 · FY2017 · GM · contact PI
Genomics-Accelerated Natural Product Discovery$250,089
R01 · FY2017 · GM · contact PI
Characterization of YcaO-Dependent Natural Product Biosynthetic Pathways$304,350
R01 · FY2016 · GM · contact PI
Chemical and biological exploration of a new natural product family, the thiazole$276,447
R01 · FY2015 · GM · contact PI
Chemical and biological exploration of a new natural product family, the thiazole$272,797
R01 · FY2014 · GM · contact PI
Chemical and biological exploration of a new natural product family, the thiazole$259,097
R01 · FY2013 · GM · contact PI
Chemical and biological exploration of a new natural product family, the thiazole$257,599
R01 · FY2012 · GM · contact PI
A common denominator of pathogenesis; a rare opportunity for novel therapeutic de$2,377,500
DP2 · FY2011 · OD · contact PI